secwatch.observer — SEC 8-K summary
======================================

Issuer:     CERO THERAPEUTICS HOLDINGS, INC. (CERO)
CIK:        0001870404
Form:       8-K
Filed at:   2026-08-31T20:52:35+00:00
Accession:  0001213900-26-095776
Event type: debt
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 1.02, 2.03, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CERo Therapeutics secures up to $11.67M senior secured note with SRX Global
---------------------------------------------------------------------------

- Consolidates prior notes of $5,666,108.77 (SRX $2,794,000; Keystone $2,872,108.77) plus up to $6M additional advances.
- Initial advance of $775,665 on Aug 27, 2026; proceeds for trade payables and working capital.
- 10% annual interest (24.99% on default); matures Oct 15, 2026; secured by subsidiary stock and all assets.
- Subsidiary CERo Therapeutics, Inc. guarantees payment; collateral includes IP, patents, CER-1236 assets.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1870404/000121390026095776/0001213900-26-095776-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1870404/000121390026095776/ea0304037-8k_cero.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-095776

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer